Trials / Recruiting
RecruitingNCT06533917
Spinal Cord Stimulation for Chronic Abdominal Pain Patients
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- The Leeds Teaching Hospitals NHS Trust · Academic / Other
- Sex
- All
- Age
- 18 Years – 130 Years
- Healthy volunteers
- Not accepted
Summary
Chronic abdominal pain is a common disorder that can have significant impact on the lives of patients. Treatment options include medication which can have limited effectiveness, be associated with side effects and may lead to tolerance and dependency. Spinal cord stimulation (SCS) is a minimally invasive, therapeutic option for managing chronic abdominal pain. This involves implanting a device that delivers mild electrical signals to the spinal cord to reduce pain. Conventional SCS has been shown to improve abdominal pain caused by different disorders, but it causes feelings of unpleasant tingling in the tummy area. This feasibility study aims to explore relief from chronic abdominal pain symptoms when using a device that does not cause uncomfortable tingling feelings in the tummy area.
Detailed description
Up to 20 patients with chronic abdominal pain will be recruited to participate in this study. They will attend an initial visit prior to having the device implanted and they will be asked to complete a number of questionnaires. Participants will then attend the hospital to have the device implanted and the treatment settings of the stimulation adjusted. Once the stimulation is started, participants will be continuously monitored for their well-being through a series of in-person visits at the pain clinic on a regular basis. These will happen at 1 week and 3, 6 and 12 months after having the device implanted.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Main Group | Thoracolumbar spine AP, Thoracolumbar spine LAT |
Timeline
- Start date
- 2024-01-18
- Primary completion
- 2025-06-04
- Completion
- 2025-06-04
- First posted
- 2024-08-01
- Last updated
- 2024-08-15
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT06533917. Inclusion in this directory is not an endorsement.